Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Construction in Progress (2023 - 2024)

Historic Construction in Progress for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Q4 2024 value amounting to $1.4 million.

  • Zhengye Biotechnology Holding's Construction in Progress rose 2834.89% to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year increase of 2834.89%. This contributed to the annual value of $1.3 million for FY2024, which is 2396.98% up from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Construction in Progress stood at $1.4 million for Q4 2024, which was up 2834.89% from $1.1 million recorded in Q4 2023.
  • Zhengye Biotechnology Holding's Construction in Progress' 5-year high stood at $1.4 million during Q4 2024, with a 5-year trough of $1.1 million in Q4 2023.